Oxford Immunotec Global PLC (NASDAQ:OXFD) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued on Thursday. The brokerage currently has a $17.00 target price on the stock. Zacks Investment Research’s price target points to a potential upside of 13.71% from the stock’s current price. According […]